- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07539831
Effects of Menstrual Cycle on Optic Nerve Sheath Diameter in Patients Undergoing Laparoscopic Gynecologic Surgery
April 20, 2026 updated by: Mahmut Sami TUTAR, Konya City Hospital
The Effect of Menstrual Cycle Phase on Optic Nerve Sheath Diameter in Patients Undergoing Laparoscopic Gynecologic Surgery
This observational study aims to evaluate the effect of menstrual cycle phase on optic nerve sheath diameter (ONSD) in women undergoing elective laparoscopic gynecologic surgery.
Patients will be grouped according to menstrual cycle phase as follicular or luteal.
ONSD measurements will be performed perioperatively, and postoperative nausea and vomiting as well as postoperative cognitive function will also be assessed.
The study is designed to investigate whether hormonal variations during the menstrual cycle are associated with differences in intracranial pressure reflected by ONSD measurements and postoperative outcomes
Study Overview
Status
Recruiting
Study Type
Observational
Enrollment (Estimated)
110
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: MAHMUT TUTAR, MD
- Phone Number: 905552723704
- Email: masatu42@gmail.com
Study Contact Backup
- Name: MAHMUT TUTAR, md
Study Locations
-
-
-
Konya, Turkey (Türkiye)
- Recruiting
- Konya City Hospital
-
Contact:
- MAHMUT TUTAR, MD
- Phone Number: 905552723704
- Email: masatu42@gmail.com
-
Contact:
- MAHMUT TUTAR
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Women aged 18 to 45 years with ASA physical status I-II who are scheduled for elective laparoscopic gynecologic surgery at Konya City Hospital.
Participants will be observed according to menstrual cycle phase (follicular or luteal phase).
Description
Inclusion Criteria:
- Female patients aged 18 to 45 years
- Scheduled for elective laparoscopic gynecologic surgery
- Menstrual cycle in the follicular phase or luteal phase
- American Society of Anesthesiologists (ASA) physical status I-II
Exclusion Criteria:
- Irregular menstrual cycle (e.g., polycystic ovary syndrome, early menopause, hypothalamic amenorrhea)
- Pregnancy or breastfeeding
- Neurological disease associated with intracranial pressure changes
- Glaucoma or another eye disease associated with high intraocular pressure
- Previous brain surgery
- Uncontrolled hypertension or severe cardiovascular disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Follicular Phase
Women undergoing elective laparoscopic gynecologic surgery during the follicular phase of the menstrual cycle (approximately days 12-14).
Perioperative optic nerve sheath diameter measurements will be performed, and postoperative nausea, vomiting, and cognitive function will be assessed.
|
|
Luteal Phase
Women undergoing elective laparoscopic gynecologic surgery during the luteal phase of the menstrual cycle (approximately days 20-25).
Perioperative optic nerve sheath diameter measurements will be performed, and postoperative nausea, vomiting, and cognitive function will be assessed.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Optic Nerve Sheath Diameter
Time Frame: Before induction of anesthesia, during surgery, and at the end of surgery
|
The primary outcome is the comparison of optic nerve sheath diameter (ONSD) between women in the follicular phase and those in the luteal phase of the menstrual cycle undergoing elective laparoscopic gynecologic surgery.
ONSD will be measured ultrasonographically in the supine position.
For each eye, three horizontal and three vertical measurements will be obtained and averaged.
|
Before induction of anesthesia, during surgery, and at the end of surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Postoperative Nausea and Vomiting
Time Frame: Within 24 hours after surgery
|
Postoperative nausea and vomiting will be assessed using the Verbal Descriptive Scale (VDS) and compared between the follicular-phase and luteal-phase groups.
The VDS categories are none, mild, moderate, vomiting once, and severe vomiting.
|
Within 24 hours after surgery
|
|
Postoperative Cognitive Function
Time Frame: Preoperative period and 24 hours after surgery
|
Postoperative cognitive function will be assessed using the Mini-Mental State Examination (MMSE) and compared between the follicular-phase and luteal-phase groups.
|
Preoperative period and 24 hours after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: MAHMUT TUTAR, MD, Konya City Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
April 20, 2026
Primary Completion (Estimated)
March 3, 2027
Study Completion (Estimated)
April 5, 2027
Study Registration Dates
First Submitted
April 7, 2026
First Submitted That Met QC Criteria
April 13, 2026
First Posted (Actual)
April 20, 2026
Study Record Updates
Last Update Posted (Actual)
April 21, 2026
Last Update Submitted That Met QC Criteria
April 20, 2026
Last Verified
April 1, 2026
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- KSH-ANEST-2025-ONSD-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Postoperative Nausea and Vomiting
-
Hafiz Muhammad HamzaFederal Government Polyclinic (Postgraduate Medical Institute)CompletedPostoperative Nausea and Vomiting (PONV)Pakistan
-
Cukurova UniversityTarsus UniversityCompletedNausea, Postoperative | Vomiting, Postoperative | APFEL RİSK SCORETurkey
-
GlaxoSmithKlineCompletedPostoperative Nausea and Vomiting | Nausea and Vomiting, PostoperativeUnited States, Spain, Philippines, Israel, Hong Kong, Thailand, United Kingdom, Hungary, Slovenia, Norway, Denmark
-
MonoSol RxCompletedNausea With Vomiting Chemotherapy-Induced | Nausea and Vomiting, PostoperativeIndia
-
Yeungnam University College of MedicineCompletedPostoperative Nausea | Postoperative VomitingKorea, Republic of
-
Northwell HealthTerminatedPostoperative Pain | Postoperative Nausea | Postoperative VomitingUnited States
-
Hôpital Privé de Parly II - Le ChesnayCompletedPostoperative Nausea | Postoperative Vomiting | Postoperative EmesisFrance
-
Vestre VikenHF Kongsberg SykehusNorwegian Medical AssociationCompletedPostoperative Complications | Postoperative Pain | Postoperative Vomiting and Nausea | Mental Status Changes PostoperativeKazakhstan, Russian Federation
-
Muhammad IlyasNot yet recruitingNausea and Vomiting, Postoperative
-
Mengchang YangRecruitingNausea and Vomiting, PostoperativeChina